Company: Mybabybridge Inc
CEO: Abhishek Shankar
Website: https://mybabybridge.com
About Mybabybridge Inc
When we started MyBabyBridge in early 2024, our goal was simple but ambitious: to change the way fertility care is delivered by applying artificial intelligence and robotics in meaningful ways. Fertility treatments have long struggled with variability, high costs, and outcomes that too often fall short of patient hopes. As someone deeply passionate about both technology and healthcare, I saw an opportunity to bring data-driven precision and automation to a field where so much still relied on subjective judgment and trial and error.
From day one, one of the toughest challenges we faced was making sense of the incredible variety of clinical data involved. Embryo images, hormone levels, genetic information, imaging scans—each provides a piece of the puzzle but combining them effectively is complex. We invested heavily in building a team with deep expertise across fertility medicine, AI, and engineering. Together, we built machine learning models that not only analyze this data but learn and improve with every treatment cycle.
Equally important was designing our AI tools so they empower, rather than replace, clinicians. We know fertility specialists rely on years of experience and nuanced judgment. Our technology was created to provide clear insights and recommendations, helping clinicians make better-informed decisions while respecting their expertise. This collaborative approach has been key to adoption and trust in the clinic.
Another barrier we took head on is cost. IVF and related treatments are prohibitively expensive for many families. By automating labor intensive tasks and optimizing personalized medication protocols, our platform lowers costs while improving clinical outcomes. Making fertility care more affordable and accessible remains at our core.
The results speak to the hard work and innovation behind MyBabyBridge. Our AI-driven embryo selection has improved pregnancy success rates by nearly 30 percent in partnered clinics. Personalized ovarian stimulation protocols lead to more mature eggs retrieved per cycle. Automated sperm assessments reduce human variability, and AI-powered imaging catches pathologies earlier than traditional methods. Altogether, this has enabled a 40 percent decrease in diagnostic errors and stronger cycle-to-cycle consistency even for challenging cases.
What excites me most is how our platform continuously learns from tens of thousands of historical treatments, becoming smarter with every cycle. This dynamic approach is laying the foundation for truly personalized fertility medicine, where every patient receives care tailored to their unique biology and circumstances.
We built MyBabyBridge on the belief that technology can transform fertility care from an unpredictable art into a precise, accessible science. This vision drives us each day as we grow clinical partnerships, advance our AI capabilities, and work toward a future where every family has a real chance at bringing their baby home.